By Nathan Hale ( March 24, 2016, 12:03 AM EDT) -- A lack of definitive rulings from the Federal Circuit on certain issues in Shire's suit over Actavis' proposed generic version of its gastrointestinal drug Lialda emerged as a major point of contention during closing arguments Wednesday in a Florida federal court, in its second bench trial on the matter....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.